ANG Lifesciences India (BOM:540694) 3-Year EBITDA Growth Rate : 22.60% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is ANG Lifesciences India 3-Year EBITDA Growth Rate?

ANG Lifesciences India's EBITDA per Share for the three months ended in Dec. 2023 was ₹-1.48.

During the past 12 months, ANG Lifesciences India's average EBITDA Per Share Growth Rate was -84.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 22.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 39.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 30.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of ANG Lifesciences India was 93.90% per year. The lowest was 9.20% per year. And the median was 23.75% per year.

Competitive Comparison of ANG Lifesciences India's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, ANG Lifesciences India's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ANG Lifesciences India's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ANG Lifesciences India's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where ANG Lifesciences India's 3-Year EBITDA Growth Rate falls into.

ANG Lifesciences India 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

ANG Lifesciences India (BOM:540694) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

ANG Lifesciences India 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of ANG Lifesciences India's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

ANG Lifesciences India (BOM:540694) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ANG Lifesciences India Ltd (BOM:540694) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Ranjit Avenue, B-Block, Darbara Complex, SCO 113, First Floor, District Shopping Complex, Amritsar, PB, IND, 143001

Website

https://www.anglifesciences.com

ANG Lifesciences India Ltd is an India-based engaged in the manufacturing of finished pharmaceutical formulations in the form of dry powder for injections. Geographically, the company carries out sales within India, as well as outside India; generating the majority of revenue from the sales of injections within India.

ANG Lifesciences India (BOM:540694) Headlines

No Headlines